相关实验视频

Updated: Jul 31, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

胰岛素样生长因子2减轻了饮食诱导的肥胖小鼠的代谢炎症和相关的认知障碍

Xueqin Liu¹, Ling Chen¹, Yunfeng Chen¹

¹Department of Endocrinology and Metabolism, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.

Diabetes, obesity & metabolism

|December 15, 2025

概括

胰岛素类生长因子2 (IGF2) 将炎症性M1脂肪组织巨细胞 (ATM) 转移到抗炎M2类型,改善肥胖小鼠的代谢功能障碍和认知缺陷. 这项研究突出了IGF2的重点.

科学领域:

代谢性疾病研究研究.
免疫学免疫学免疫学
神经科学是一个神经科学.

背景情况:

肥胖是一种慢性炎症性疾病,与代谢并发症和神经系统疾病有关.
脂肪组织巨细胞 (ATM) 在与肥胖相关的炎症中起着关键作用,M1 ATM促进炎症,M2 ATM解决炎症.
胰岛素类生长因子2 (IGF2) 在ATM两极化中的作用及其对肥胖相关炎症和认知功能的影响尚不清楚.

研究的目的:

阐明IGF2在肥胖相关代谢炎症中的调节作用和潜在机制.
在肥胖的背景下,研究IGF2对ATM极化的影响.
确定IGF2对肥胖模型认知功能的影响.

主要方法:

建立高脂肪饮食 (HFD) 诱导的肥胖小鼠模型.
通过腹腔内注射进行重组IGF2 (rIGF2) 的干预.
分析ATM极化,炎症因素,上腺激素信号,脂解/热生成标记物和海马突触蛋白,使用qPCR,免疫光和西部斑点.
通过行为测试评估认知功能.

主要成果:

rIGF2治疗促进了M1到M2的ATM两极分化,减少了促炎因素 (TNF-α,IL-1).
IGF2干预缓解了β-上腺体信号通路的抑制,增强了脂解和热生成 (HSL,UCP1表达).
rIGF2治疗改善了胰岛素耐药性和肝硬化,提升了海马突触蛋白的调节,并改善了HFD诱导的认知障碍.

结论:

这项研究系统地阐明了IGF2在改善ATM两极化,代谢炎症,脂解热生成平衡和肥胖症认知障碍方面的双重机制.
IGF2显示出作为能量代谢调节剂的潜力,具有免疫调节和神经保护性质.
IGF2为肥胖及其相关并发症提供了一个新的治疗点.

关键词:

自动取款机自动取款机自动取款机自动取款机 IGF2 IGF2 的意思是什么认知障碍是一种认知障碍.代谢性炎症是一种代谢性炎症.肥胖肥胖肥胖肥胖肥胖肥胖肥胖肥胖

更多相关视频

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice

Published on: November 27, 2019

相关概念视频

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.